{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T02:09:37Z","timestamp":1775873377811,"version":"3.50.1"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ultraviolet radiation (UVR) induces immunosuppression and DNA damage, both of which contribute to the rising global incidence of skin cancer including melanoma. Nucleotide excision repair, which is activated upon UVR-induced DNA damage, is linked to expression of interleukin-12 (IL-12) which serves to limit immunosuppression and augment the DNA repair process. Herein, we report an immunomodulating peptide, designated IK14800, that not only elicits secretion of IL-12, interleukin-2 (IL-2) and interferon-gamma (IFN-\u03b3) but also reduces DNA damage in the skin following exposure to UVR. Combined with re-invigoration of exhausted CD4+ T cells, inhibition of UVR-induced MMP-1 release and suppression of B16F10 melanoma metastases, IK14800 offers an opportunity to gain further insight into mechanisms underlying the development and progression of skin cancers.<\/jats:p>","DOI":"10.1038\/s41598-023-38890-4","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T10:02:28Z","timestamp":1689847348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damage"],"prefix":"10.1038","volume":"13","author":[{"given":"Michael","family":"Agrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Stephen","family":"Rybchyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warusavithana Gunawardena Manori","family":"De Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca Sara","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrence J.","family":"Piva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristofer","family":"Thurecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayathri","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Blyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darryl","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Rzepecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Knox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Nika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayley","family":"Gooding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"38890_CR1","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.4049\/jimmunol.143.6.1737","volume":"143","author":"BA Araneo","year":"1989","unstructured":"Araneo, B. A., Dowell, T., Moon, H. B. & Daynes, R. A. Regulation of murine lymphokine production in vivo. Ultraviolet radiation exposure depresses IL-2 and enhances IL-4 production by T cells through an IL-1-dependent mechanism. J. Immunol. 143, 1737\u20131744 (1989).","journal-title":"J. Immunol."},{"key":"38890_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2007.02.010","volume":"255","author":"SK Katiyar","year":"2007","unstructured":"Katiyar, S. K. UV-induced immune suppression and photocarcinogenesis: Chemoprevention by dietary botanical agents. Cancer Lett. 255, 1\u201311 (2007).","journal-title":"Cancer Lett."},{"key":"38890_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fphar.2015.00056","volume":"6","author":"SY Abo Elnazar","year":"2015","unstructured":"Abo Elnazar, S. Y., Ghazy, A. A., Ghoneim, H. E., Taha, A. R. M. & Abouelella, A. M. Effect of ultra violet irradiation on the interplay between Th1 and Th2 lymphocytes. Front. Pharmacol. 6, 56 (2015).","journal-title":"Front. Pharmacol."},{"key":"38890_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-2395-1-6","volume":"1","author":"T Fulop","year":"2012","unstructured":"Fulop, T. et al. Aging, immunosenescence and membrane rafts: The lipid connection. Longev. Healthspan 1, 1\u20139 (2012).","journal-title":"Longev. Healthspan"},{"key":"38890_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486\u2013499 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"38890_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2188\/jea.JE20160166","volume":"28","author":"I Savoye","year":"2018","unstructured":"Savoye, I. et al. Patterns of ultraviolet radiation exposure and skin cancer risk: The E3N-SunExp study. J. Epidemiol. 28, 27\u201333 (2018).","journal-title":"J. Epidemiol."},{"key":"38890_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/ijms13010142","volume":"13","author":"C L\u00f3pez-Camarillo","year":"2011","unstructured":"L\u00f3pez-Camarillo, C. et al. Protein kinases and transcription factors activation in response to UV-radiation of skin: Implications for carcinogenesis. Int. J. Mol. Sci. 13, 142\u2013172 (2011).","journal-title":"Int. J. Mol. Sci."},{"key":"38890_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/em.22176","volume":"59","author":"AQ Khan","year":"2018","unstructured":"Khan, A. Q., Travers, J. B. & Kemp, M. G. Roles of UVA radiation and DNA damage responses in melanoma pathogenesis. Environ. Mol. Mutagen 59, 438\u2013460 (2018).","journal-title":"Environ. Mol. Mutagen"},{"key":"38890_CR9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1126\/science.6210958","volume":"216","author":"MS Fisher","year":"1982","unstructured":"Fisher, M. S. & Kripke, M. L. Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice. Science 216, 1133\u20131134 (1982).","journal-title":"Science"},{"key":"38890_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pbiomolbio.2006.02.009","volume":"92","author":"M Norval","year":"2006","unstructured":"Norval, M. The mechanisms and consequences of ultraviolet-induced immunosuppression. Prog. Biophys. Mol. Biol. 92, 108\u2013118 (2006).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"38890_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1756-9966-29-116","volume":"29","author":"JH Lee","year":"2010","unstructured":"Lee, J. H., Pyon, J. K. & Kim, D. W. Elevated c-Src and c-Yes expression in malignant skin cancers. J. Exp. Clin. Cancer Res. 29, 116 (2010).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"38890_CR12","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S0092-8674(05)80058-3","volume":"71","author":"Y Devary","year":"1992","unstructured":"Devary, Y., Gottlieb, R. A., Smeal, T. & Karin, M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 71, 1081\u20131091 (1992).","journal-title":"Cell"},{"key":"38890_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/carcin\/bgs358","volume":"34","author":"S Byun","year":"2013","unstructured":"Byun, S. et al. Src kinase is a direct target of apigenin against UVB-induced skin inflammation. Carcinogenesis 34, 397\u2013405 (2013).","journal-title":"Carcinogenesis"},{"key":"38890_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/emmm.201302666","volume":"6","author":"A Montagner","year":"2014","unstructured":"Montagner, A. et al. Src is activated by the nuclear receptor peroxisome proliferator-activated receptor \u03b2\/\u03b4 in ultraviolet radiation-induced skin cancer. EMBO Mol. Med. 6, 80\u201398 (2014).","journal-title":"EMBO Mol. Med."},{"key":"38890_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4236\/jct.2011.23039","volume":"2","author":"M Agrez","year":"2011","unstructured":"Agrez, M., Garg, M., Dorahy, D. & Ackland, S. Synergistic anti-tumor effect of cisplatin when combined with an anti-Src kinase integrin-based peptide. J. Cancer Therapy 2, 295\u2013301 (2011).","journal-title":"J. Cancer Therapy"},{"key":"38890_CR16","volume":"5","author":"WGM De Silva","year":"2021","unstructured":"De Silva, W. G. M. et al. Evidence for involvement of nonclassical pathways in the protection from UV-induced DNA damage by vitamin D-related compounds. J. Bone Miner. Res. Plus 5, e10555 (2021).","journal-title":"J. Bone Miner. Res. Plus"},{"key":"38890_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/jidsymp.2009.3","volume":"14","author":"T Schwarz","year":"2009","unstructured":"Schwarz, T. & Schwarz, A. DNA repair and cytokine responses. J. Investig. Dermatol. Symp. Proc. 14, 63\u201366 (2009).","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"38890_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/ncb717","volume":"4","author":"A Schwarz","year":"2002","unstructured":"Schwarz, A. et al. Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat. Cell Biol. 4, 26\u201331 (2002).","journal-title":"Nat. Cell Biol."},{"key":"38890_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1084\/jem.20041212","volume":"201","author":"A Schwarz","year":"2005","unstructured":"Schwarz, A. et al. Prevention of UV radiation-induced immunosuppression by IL-12 is dependent on DNA repair. J. Exp. Med. 201, 173\u2013179 (2005).","journal-title":"J. Exp. Med."},{"key":"38890_CR20","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.4049\/jimmunol.176.5.2896","volume":"176","author":"A Schwarz","year":"2006","unstructured":"Schwarz, A., Maeda, A., St\u00e4nder, S., van Steeg, H. & Schwarz, T. IL-18 reduces ultraviolet radiation-induced DNA damage and thereby affects photoimmunosuppression. J. Immunol. 176, 2896\u20132901 (2006).","journal-title":"J. Immunol."},{"key":"38890_CR21","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.molimm.2005.12.003","volume":"43","author":"M Molenda","year":"2006","unstructured":"Molenda, M., Mukkamala, L. & Blumenberg, M. Interleukin IL-12 blocks a specific subset of the transcriptional profile responsive to UVB in epidermal keratinocytes. Mol. Immunol. 43, 1933\u20131940 (2006).","journal-title":"Mol. Immunol."},{"key":"38890_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/phpp.12329","volume":"34","author":"A Sample","year":"2018","unstructured":"Sample, A. & He, Y. Y. Mechanisms and prevention of UV-induced melanoma. Photodermatol. Photoimmunol. Photomed. 34, 13\u201324 (2018).","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"38890_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2220\/biomedres.25.277","volume":"25","author":"Y Nomura","year":"2004","unstructured":"Nomura, Y. et al. Interferon-gamma liniment protects hairless mice against ultraviolet irradiation-induced skin damage. Biomed. Res. 25, 277\u2013285 (2004).","journal-title":"Biomed. Res."},{"key":"38890_CR24","first-page":"159","volume":"49","author":"L Lauerova","year":"2002","unstructured":"Lauerova, L. et al. Malignant melanoma associates with Th1\/Th2 imbalance that coincides with disease progression and immunotherapy response. Neoplasma 49, 159\u2013166 (2002).","journal-title":"Neoplasma"},{"key":"38890_CR25","first-page":"47","volume":"16","author":"R Botella-Estrada","year":"2005","unstructured":"Botella-Estrada, R. et al. Cytokine production by peripheral lymphocytes in melanoma. Eur. Cytokine Netw. 16, 47\u201355 (2005).","journal-title":"Eur. Cytokine Netw."},{"key":"38890_CR26","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.3390\/cancers14225592","volume":"14","author":"W Gao","year":"2022","unstructured":"Gao, W., Pan, J. & Pan, J. Antitumor activities of interleukin-12 in melanoma. Cancers 14, 5592 (2022).","journal-title":"Cancers"},{"key":"38890_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1189\/jlb.69.1.113","volume":"69","author":"AP Makrigiannis","year":"2001","unstructured":"Makrigiannis, A. P., Musgrave, B. L., Haeryfar, S. M. & Hoskin, D. W. Interleukin-12 can replace CD28-dependent T-cell costimulation during nonspecific cytotoxic T lymphocyte induction by anti-CD3 antibody. J. Leukoc. Biol. 69, 113\u2013122 (2001).","journal-title":"J. Leukoc. Biol."},{"key":"38890_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4137\/CMO.S11292","volume":"7","author":"MA Michelin","year":"2013","unstructured":"Michelin, M. A., Abdalla, D. R., Aleixo, A. A. & Murta, E. F. Peripheral helper lymphocytes produce interleukin 12 in cancer patients. Clin. Med. Insights Oncol. 7, 75\u201381 (2013).","journal-title":"Clin. Med. Insights Oncol."},{"key":"38890_CR29","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/ncomms2223","volume":"3","author":"M Kuka","year":"2012","unstructured":"Kuka, M., Munitic, I. & Ashwell, J. D. Identification and characterization of polyclonal \u03b1\u03b2-T cells with dendritic cell properties. Nat. Commun. 3, 1223 (2012).","journal-title":"Nat. Commun."},{"key":"38890_CR30","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2936::AID-IMMU2936>3.0.CO;2-I","volume":"28","author":"IB Kremer","year":"1998","unstructured":"Kremer, I. B., Cooper, K. D., Teunissen, M. B. & Stevens, S. R. Low expression of CD40 and B7 on macrophages infiltrating UV-exposed human skin; role in IL-2R\u03b1\u2212 T cell activation. Eur. J. Immunol. 28, 2936\u20132946 (1998).","journal-title":"Eur. J. Immunol."},{"key":"38890_CR31","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.4049\/jimmunol.160.4.1701","volume":"160","author":"JF McDyer","year":"1998","unstructured":"McDyer, J. F., Goletz, T. J., Thomas, E., June, C. H. & Seder, R. A. CD40 ligand\/CD40 stimulation regulates the production of IFN-\u03b3 from human peripheral blood mononuclear cells in an IL-12-and\/or CD28-dependent manner. J. Immunol. 160, 1701\u20131707 (1998).","journal-title":"J. Immunol."},{"key":"38890_CR32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4049\/jimmunol.167.1.221","volume":"167","author":"U Grohmann","year":"2001","unstructured":"Grohmann, U. et al. Positive regulatory role of IL-12 in macrophages and modulation by IFN-\u03b3. J. Immunol. 167, 221\u2013227 (2001).","journal-title":"J. Immunol."},{"key":"38890_CR33","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.4049\/jimmunol.154.10.5114","volume":"154","author":"DA Schmitt","year":"1995","unstructured":"Schmitt, D. A., Owen-Schaub, L. & Ullrich, S. E. Effect of IL-12 on immune suppression and suppressor cell induction by ultraviolet radiation. J. Immunol. 154, 5114\u20135120 (1995).","journal-title":"J. Immunol."},{"key":"38890_CR34","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/1523-1747.ep12347944","volume":"106","author":"A Schwarz","year":"1996","unstructured":"Schwarz, A. et al. Interleukin-12 prevents ultraviolet B-induced local immunosuppression and overcomes UVB-induced tolerance. J. Invest. Dermatol. 106, 1187\u20131191 (1996).","journal-title":"J. Invest. Dermatol."},{"key":"38890_CR35","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1046\/j.1365-2567.1999.00801.x","volume":"97","author":"J Garssen","year":"1999","unstructured":"Garssen, J. et al. UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology 97, 506\u2013514 (1999).","journal-title":"Immunology"},{"key":"38890_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/039463200201500101","volume":"15","author":"S Kasahara","year":"2002","unstructured":"Kasahara, S., Wago, H. & Cooper, E. L. Dissociation of innate and adaptive immunity by UVB irradiation. Int. J. Immunopathol. Pharmacol. 15, 1\u201311 (2002).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"38890_CR37","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.4049\/jimmunol.1400985","volume":"193","author":"S Yamazaki","year":"2014","unstructured":"Yamazaki, S. et al. Homeostasis of thymus-derived Foxp3+ regulatory T cells is controlled by ultraviolet B exposure in the skin. J. Immunol. 193, 5488\u20135497 (2014).","journal-title":"J. Immunol."},{"key":"38890_CR38","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1158\/0008-5472.CAN-05-3614","volume":"66","author":"A Maeda","year":"2006","unstructured":"Maeda, A. et al. Enhanced photocarcinogenesis in interleukin-12\u2013deficient mice. Cancer Res. 66, 2962\u20132969 (2006).","journal-title":"Cancer Res."},{"key":"38890_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/cdd.2014.134","volume":"22","author":"S Tugues","year":"2015","unstructured":"Tugues, S. et al. New insights into IL-12-mediated tumor suppression. Cell Death Differ. 22, 237\u2013246 (2015).","journal-title":"Cell Death Differ."},{"key":"38890_CR40","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.4049\/jimmunol.172.7.3983","volume":"172","author":"BH Nelson","year":"2004","unstructured":"Nelson, B. H. IL-2, regulatory T cells, and tolerance. J. Immunol. 172, 3983\u20133988 (2004).","journal-title":"J. Immunol."},{"key":"38890_CR41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/BF02918286","volume":"15","author":"C Caruso","year":"1996","unstructured":"Caruso, C. et al. Cytokine production pathway in the elderly. Immunol. Res. 15, 84\u201390 (1996).","journal-title":"Immunol. Res."},{"key":"38890_CR42","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cyto.2014.11.024","volume":"71","author":"MY Balkhi","year":"2015","unstructured":"Balkhi, M. Y., Ma, Q., Ahmad, S. & Junghans, R. P. T cell exhaustion and Interleukin 2 downregulation. Cytokine 71, 339\u2013347 (2015).","journal-title":"Cytokine"},{"key":"38890_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2174\/1573395054065115","volume":"1","author":"J Liu","year":"2005","unstructured":"Liu, J. et al. Interleukin-12: An update on its immunological activities, signaling and regulation of gene expression. Curr. Immunol. Rev. 1, 119\u2013137 (2005).","journal-title":"Curr. Immunol. Rev."},{"key":"38890_CR44","doi-asserted-by":"publisher","first-page":"633","DOI":"10.4049\/jimmunol.166.1.633","volume":"166","author":"S Ebner","year":"2001","unstructured":"Ebner, S. et al. Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation and is further enhanced by IL-4. J. Immunol. 166, 633\u2013641 (2001).","journal-title":"J. Immunol."},{"key":"38890_CR45","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2015","unstructured":"Elgueta, R. et al. Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol. Rev. 229, 152\u2013172 (2015).","journal-title":"Immunol. Rev."},{"key":"38890_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fimmu.2013.00107","volume":"4","author":"MA Moro-Garc\u00eda","year":"2013","unstructured":"Moro-Garc\u00eda, M. A., Alonso-Arias, R. & L\u00f3pez-Larrea, C. When aging reaches CD4+ T-cells: Phenotypic and functional changes. Front. Immunol. 4, 107 (2013).","journal-title":"Front. Immunol."},{"key":"38890_CR47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12979-022-00273-0","volume":"19","author":"DM Matthe","year":"2022","unstructured":"Matthe, D. M., Thoma, O. M., Sperka, T., Neurath, M. F. & Waldner, M. J. Telomerase deficiency reflects age-associated changes in CD4+ T cells. Immun. Ageing 19, 16 (2022).","journal-title":"Immun. Ageing"},{"key":"38890_CR48","doi-asserted-by":"publisher","first-page":"6301","DOI":"10.4049\/jimmunol.165.11.6301","volume":"165","author":"AN Vallejo","year":"2000","unstructured":"Vallejo, A. N., Schirmer, M., Weyand, C. M. & Goronzy, J. J. Clonality and longevity of CD4+ CD28null T cells are associated with defects in apoptotic pathways. J. Immunol. 165, 6301\u20136307 (2000).","journal-title":"J. Immunol."},{"key":"38890_CR49","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1073\/pnas.0812851107","volume":"107","author":"D Busse","year":"2010","unstructured":"Busse, D. et al. Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments. Proc. Natl. Acad. Sci. U. S. A. 107, 3058\u20133063 (2010).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"38890_CR50","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/intimm\/9.8.1095","volume":"9","author":"YQ Zhang","year":"1997","unstructured":"Zhang, Y. Q. et al. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses. Int. Immunol. 9, 1095\u20131102 (1997).","journal-title":"Int. Immunol."},{"key":"38890_CR51","doi-asserted-by":"publisher","first-page":"5432","DOI":"10.4049\/jimmunol.1500707","volume":"195","author":"HS Lim","year":"2015","unstructured":"Lim, H. S. et al. Costimulation of IL-2 production through CD28 is dependent on the size of its ligand. J. Immunol. 195, 5432\u20135439 (2015).","journal-title":"J. Immunol."},{"key":"38890_CR52","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1182\/blood-2002-08-2574","volume":"101","author":"KJ Warrington","year":"2003","unstructured":"Warrington, K. J., Vallejo, A. N., Weyand, C. M. & Goronzy, J. J. CD28 loss in senescent CD4+ T cells: Reversal by interleukin-12 stimulation. Blood 101, 3543\u20133549 (2003).","journal-title":"Blood"},{"key":"38890_CR53","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejpb.2008.10.016","volume":"72","author":"A Kloss","year":"2009","unstructured":"Kloss, A. et al. The cell-penetrating peptide octa-arginine is a potent inhibitor of proteasome activities. Eur. J. Pharm. Biopharm. 72, 219\u2013225 (2009).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"38890_CR54","doi-asserted-by":"publisher","first-page":"11185","DOI":"10.1038\/s41598-022-15455-5","volume":"12","author":"M Agrez","year":"2022","unstructured":"Agrez, M. et al. A novel lipidic peptide with potential to promote balanced effector-regulatory T cell responses. Sci. Rep. 12, 11185 (2022).","journal-title":"Sci. Rep."},{"key":"38890_CR55","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/sj.embor.7401099","volume":"8","author":"MF Bachmann","year":"2007","unstructured":"Bachmann, M. F. & Oxenius, A. Interleukin 2: From immunostimulation to immunoregulation and back again. EMBO Rep. 8, 1142\u20131148 (2007).","journal-title":"EMBO Rep."},{"key":"38890_CR56","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1002\/eji.200425274","volume":"34","author":"M de la Rosa","year":"2004","unstructured":"de la Rosa, M., Rutz, S., Dorninger, H. & Scheffold, A. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34, 2480\u20132488 (2004).","journal-title":"Eur. J. Immunol."},{"key":"38890_CR57","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nri3156","volume":"12","author":"O Boyman","year":"2012","unstructured":"Boyman, O. & Sprent, J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 12, 180\u2013190 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"38890_CR58","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1073\/pnas.86.4.1333","volume":"86","author":"CB Thompson","year":"1989","unstructured":"Thompson, C. B. et al. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines\/cytokines. Proc. Natl. Acad. Sci. U. S. A. 86, 1333\u20131337 (1989).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"38890_CR59","doi-asserted-by":"publisher","first-page":"18336","DOI":"10.1073\/pnas.1110566108","volume":"108","author":"DK Sojka","year":"2011","unstructured":"Sojka, D. K. & Fowell, D. J. Regulatory T cells inhibit acute IFN-\u03b3 synthesis without blocking T-helper cell type 1 (Th1) differentiation via a compartmentalized requirement for IL-10. Proc. Natl. Acad. Sci. U. S. A. 108, 18336\u201318341 (2011).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"38890_CR60","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.4049\/jimmunol.159.5.2125","volume":"159","author":"HJ Ahn","year":"1997","unstructured":"Ahn, H. J. et al. A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma. J. Immunol. 159, 2125\u20132131 (1997).","journal-title":"J. Immunol."},{"key":"38890_CR61","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/CJI.0b013e318165f5d2","volume":"31","author":"AS Kaka","year":"2008","unstructured":"Kaka, A. S., Foster, A. E., Weiss, H. L., Rooney, C. M. & Leen, A. M. Using dendritic cell maturation and IL-12 producing capacity as markers of function: A cautionary tale. J. Immunother. 31, 359\u2013369 (2008).","journal-title":"J. Immunother."},{"key":"38890_CR62","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cyto.2015.07.026","volume":"76","author":"K Abdi","year":"2015","unstructured":"Abdi, K. & Singh, N. J. Making many from few: IL-12p40 as a model for the combinatorial assembly of heterodimeric cytokines. Cytokine 76, 53\u201357 (2015).","journal-title":"Cytokine"},{"key":"38890_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106458","volume":"9","author":"K Zhao","year":"2014","unstructured":"Zhao, K. et al. Wogonin suppresses melanoma cell B16\u2013F10 invasion and migration by inhibiting Ras-medicated pathways. PLoS ONE 9, e106458 (2014).","journal-title":"PLoS ONE"},{"key":"38890_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206693","volume":"13","author":"M Potez","year":"2018","unstructured":"Potez, M. et al. Characterization of a B16\u2013F10 melanoma model locally implanted into the ear pinnae of C57BL\/6 mice. PLoS ONE 13, e0206693 (2018).","journal-title":"PLoS ONE"},{"key":"38890_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123332","volume":"10","author":"MP Rausch","year":"2015","unstructured":"Rausch, M. P. & Hastings, K. T. An exhaustion-like phenotype constrains the activity of CD4+ T cells specific for a self and melanoma antigen. PLoS ONE 10, e0123332 (2015).","journal-title":"PLoS ONE"},{"key":"38890_CR66","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1158\/1940-6207.CAPR-11-0165","volume":"4","author":"KM Dixon","year":"2011","unstructured":"Dixon, K. M. et al. 1\u03b1,25(OH)2-vitamin D and a nongenomic vitamin D analogue inhibit ultraviolet radiation-induced skin carcinogenesis. Cancer Prev. Res. 4, 1485\u20131494 (2011).","journal-title":"Cancer Prev. Res."},{"key":"38890_CR67","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1248\/bpb.31.1265","volume":"31","author":"YA Lee","year":"2008","unstructured":"Lee, Y. A., Cho, E. J. & Yokozawa, T. Protective effect of persimmon (Diospyros kaki) peel proanthocyanidin against oxidative damage under H2O2-induced cellular senescence. Biol. Pharm. Bull. 31, 1265\u20131269 (2008).","journal-title":"Biol. Pharm. Bull."},{"key":"38890_CR68","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.jid.2017.11.037","volume":"138","author":"MS Rybchyn","year":"2018","unstructured":"Rybchyn, M. S. et al. Enhanced repair of UV-induced DNA damage by 1,25-dihydroxyvitamin D3 in skin is linked to pathways that control cellular energy. J. Invest. Dermatol. 138, 1146\u20131156 (2018).","journal-title":"J. Invest. Dermatol."},{"key":"38890_CR69","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3390\/ijms17060868","volume":"17","author":"P Pittayapruek","year":"2016","unstructured":"Pittayapruek, P., Meephansan, J., Prapapan, O., Komine, M. & Ohtsuki, M. Role of matrix metalloproteinases in photoaging and photocarcinogenesis. Int. J. Mol. Sci. 17, 868 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"38890_CR70","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.1600-0625.2008.00747.x","volume":"17","author":"KK Dong","year":"2008","unstructured":"Dong, K. K. et al. UV-induced DNA damage initiates release of MMP-1 in human skin. Exp. Dermatol. 17, 1037\u20131044 (2008).","journal-title":"Exp. Dermatol."},{"key":"38890_CR71","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.biocel.2005.02.015","volume":"37","author":"A Van Laethem","year":"2005","unstructured":"Van Laethem, A., Claerhout, S., Garmyn, M. & Agostinis, P. The sunburn cell: Regulation of death and survival of the keratinocyte. Int. J. Biochem. 37, 1547\u20131553 (2005).","journal-title":"Int. J. Biochem."},{"key":"38890_CR72","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/1523-1747.ep12285640","volume":"108","author":"B Lehmann","year":"1997","unstructured":"Lehmann, B. HaCaT cell line as a model system for vitamin D3 metabolism in human skin. J. Invest. Dermatol. 108, 78\u201382 (1997).","journal-title":"J. Invest. Dermatol."},{"key":"38890_CR73","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1021\/bi035933x","volume":"43","author":"SM Fuchs","year":"2004","unstructured":"Fuchs, S. M. & Raines, R. T. Pathway for polyarginine entry into mammalian cells. Biochemistry 43, 2438\u20132444 (2004).","journal-title":"Biochemistry"},{"key":"38890_CR74","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1021\/mp500203e","volume":"11","author":"D Oh","year":"2014","unstructured":"Oh, D. et al. Enhanced cellular uptake of short polyarginine peptides through fatty acylation and cyclization. Mol. Pharm. 11, 2845\u20132854 (2014).","journal-title":"Mol. Pharm."},{"key":"38890_CR75","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.1074\/jbc.M007540200","volume":"276","author":"S Futaki","year":"2001","unstructured":"Futaki, S. et al. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276, 5836\u20135840 (2001).","journal-title":"J. Biol. Chem."},{"key":"38890_CR76","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.bbrc.2005.04.023","volume":"331","author":"X Zhang","year":"2005","unstructured":"Zhang, X. et al. Nuclear localization signal of ING4 plays a key role in its binding to p53. Biochem. Biophys. Res. Commun. 331, 1032\u20131038 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"38890_CR77","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1101\/gad.13.7.768","volume":"13","author":"WL de Laat","year":"1999","unstructured":"de Laat, W. L., Jaspers, N. G. & Hoeijmakers, J. H. Molecular mechanism of nucleotide excision repair. Genes Dev. 13, 768\u2013785 (1999).","journal-title":"Genes Dev."},{"key":"38890_CR78","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.jid.2020.11.033","volume":"141","author":"CT Wong","year":"2021","unstructured":"Wong, C. T. & Oh, D. H. Vitamin D receptor promotes global nucleotide excision repair by facilitating XPC dissociation from damaged DNA. J. Invest. Dermatol. 141, 1656\u20131663 (2021).","journal-title":"J. Invest. Dermatol."},{"key":"38890_CR79","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1172\/JCI1050","volume":"101","author":"D D'Ambrosio","year":"1998","unstructured":"D\u2019Ambrosio, D. et al. Inhibition of IL-12 production by 1, 25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Investig. 101, 252\u2013262 (1998).","journal-title":"J. Clin. Investig."},{"key":"38890_CR80","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.4049\/jimmunol.1500546","volume":"197","author":"V Chiurchi\u00f9","year":"2016","unstructured":"Chiurchi\u00f9, V. et al. Anandamide suppresses proinflammatory T cell responses in vitro through type-1 cannabinoid receptor\u2013mediated mTOR inhibition in human keratinocytes. J. Immunol. 197, 3545\u20133553 (2016).","journal-title":"J. Immunol."},{"key":"38890_CR81","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7435621","volume":"2017","author":"I Colombo","year":"2017","unstructured":"Colombo, I. et al. HaCaT cells as a reliable in vitro differentiation model to dissect the inflammatory\/repair response of human keratinocytes. Mediators Inflamm. 2017, 743621 (2017).","journal-title":"Mediators Inflamm."},{"key":"38890_CR82","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/jid.2012.288","volume":"133","author":"E Harberts","year":"2013","unstructured":"Harberts, E. & Gaspari, A. A. TLR signaling and DNA repair: Are they associated?. J. Invest. Dermatol. 133, 296\u2013302 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"38890_CR83","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/jid.2013.530","volume":"134","author":"I Ahmad","year":"2014","unstructured":"Ahmad, I. et al. Toll-like receptor-4 deficiency enhances repair of UVR-induced cutaneous DNA damage by nucleotide excision repair mechanism. J. Invest. Dermatol. 134, 1710\u20131717 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"38890_CR84","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1365-2567.2005.02122.x","volume":"114","author":"G K\u00f6llisch","year":"2005","unstructured":"K\u00f6llisch, G. et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 114, 531\u2013541 (2005).","journal-title":"Immunology"},{"key":"38890_CR85","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1002\/eji.1830230923","volume":"23","author":"F Mattner","year":"1993","unstructured":"Mattner, F. et al. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur. J. Immunol. 23, 2202\u20132208 (1993).","journal-title":"Eur. J. Immunol."},{"key":"38890_CR86","doi-asserted-by":"publisher","first-page":"F1000 Faculty R","DOI":"10.12688\/f1000research.7010.1","volume":"4","author":"X Ma","year":"2015","unstructured":"Ma, X. et al. Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells. F1000Research 4, F1000 Faculty Rev-1465 (2015).","journal-title":"F1000Research"},{"key":"38890_CR87","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1093\/intimm\/12.11.1531","volume":"12","author":"A Boonstra","year":"2000","unstructured":"Boonstra, A. et al. UVB irradiation modulates systemic immune responses by affecting cytokine production of antigen-presenting cells. Int. Immunol. 12, 1531\u20131538 (2000).","journal-title":"Int. Immunol."},{"key":"38890_CR88","doi-asserted-by":"publisher","first-page":"485","DOI":"10.4049\/jimmunol.146.2.485","volume":"146","author":"JC Simon","year":"1991","unstructured":"Simon, J. C., Tigelaar, R. E., Bergstresser, P. R., Edelbaum, D. & Cruz, P. D. Jr. Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells. Induction of specific clonal anergy in CD4+ T helper 1 cells. J. Immunol. 146, 485\u2013491 (1991).","journal-title":"J. Immunol."},{"key":"38890_CR89","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41417-020-0183-x","volume":"28","author":"RE Tay","year":"2021","unstructured":"Tay, R. E., Richardson, E. K. & Toh, H. C. Revisiting the role of CD4+ T cells in cancer immunotherapy-new insights into old paradigms. Cancer Gene Ther. 28, 5\u201317 (2021).","journal-title":"Cancer Gene Ther."},{"key":"38890_CR90","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.4049\/jimmunol.161.7.3400","volume":"161","author":"T Yoshimoto","year":"1998","unstructured":"Yoshimoto, T. et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J. Immunol. 161, 3400\u20133407 (1998).","journal-title":"J. Immunol."},{"key":"38890_CR91","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1751-1097.1995.tb09148.x","volume":"62","author":"HL Gensler","year":"1995","unstructured":"Gensler, H. L., Simpson, J., Gerrish, K. & Gilmore, J. Reduction of interferon-gamma as a critical mechanism by which ultraviolet radiation prevents tumor rejection. Photochem. Photobiol. 62, 862\u2013868 (1995).","journal-title":"Photochem. Photobiol."},{"key":"38890_CR92","doi-asserted-by":"publisher","first-page":"6803","DOI":"10.4049\/jimmunol.165.12.6803","volume":"165","author":"VA Lawless","year":"2000","unstructured":"Lawless, V. A. et al. Stat4 regulates multiple components of IFN-\u03b3-inducing signaling pathways. J. Immunol. 165, 6803\u20136808 (2000).","journal-title":"J. Immunol."},{"key":"38890_CR93","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fimmu.2014.00190","volume":"5","author":"ND Verma","year":"2014","unstructured":"Verma, N. D. et al. Interleukin-12 (IL-12p70) promotes induction of highly potent Th1-like CD4+ CD25+ T regulatory cells that inhibit allograft rejection in unmodified recipients. Front. Immunol. 5, 190 (2014).","journal-title":"Front. Immunol."},{"key":"38890_CR94","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.4049\/jimmunol.0800276","volume":"183","author":"S Brahmachari","year":"2009","unstructured":"Brahmachari, S. & Pahan, K. Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide. J. Immunol. 183, 2045\u20132058 (2009).","journal-title":"J. Immunol."},{"key":"38890_CR95","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nri727","volume":"2","author":"AH Sharpe","year":"2002","unstructured":"Sharpe, A. H. & Freeman, G. J. The B7\u2013CD28 superfamily. Nat. Rev. Immunol. 2, 116\u2013126 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"38890_CR96","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold, M. et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol. 158, 495\u2013503 (2022).","journal-title":"JAMA Dermatol."},{"key":"38890_CR97","first-page":"98","volume":"2","author":"K Urban","year":"2021","unstructured":"Urban, K., Mehrmal, S., Uppal, P., Giesey, R. L. & Delost, G. R. The global burden of skin cancer: A longitudinal analysis from the Global Burden of Disease Study, 1990\u20132017. J. Am. Acad. Dermatol. Int. 2, 98\u2013108 (2021).","journal-title":"J. Am. Acad. Dermatol. Int."},{"key":"38890_CR98","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1002\/cam4.4046","volume":"10","author":"W Zhang","year":"2021","unstructured":"Zhang, W. et al. Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019. Cancer Med. 10, 4905\u20134922 (2021).","journal-title":"Cancer Med."},{"key":"38890_CR99","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.4049\/jimmunol.169.5.2736","volume":"169","author":"JF McDyer","year":"2002","unstructured":"McDyer, J. F. et al. IL-2 receptor blockade inhibits late, but not early, IFN-\u03b3 and CD40 ligand expression in human T cells: Disruption of both IL-12-dependent and-independent pathways of IFN-\u03b3 production. J. Immunol. 169, 2736\u20132746 (2002).","journal-title":"J. Immunol."},{"key":"38890_CR100","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/labinvest.2016.155","volume":"97","author":"CP Day","year":"2017","unstructured":"Day, C. P., Marchalik, R., Merlino, G. & Michael, H. Mouse models of UV-induced melanoma: Genetics, pathology, and clinical relevance. Lab. Invest. 97, 698\u2013705 (2017).","journal-title":"Lab. Invest."},{"key":"38890_CR101","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/377169a0","volume":"377","author":"A Vries","year":"1995","unstructured":"Vries, A. et al. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature 377, 169\u2013173 (1995).","journal-title":"Nature"},{"key":"38890_CR102","doi-asserted-by":"publisher","first-page":"5516","DOI":"10.4049\/jimmunol.161.10.5516","volume":"161","author":"J Wang","year":"1998","unstructured":"Wang, J., Saffold, S., Cao, X., Krauss, J. & Chen, W. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. J. Immunol. 161, 5516\u20135524 (1998).","journal-title":"J. Immunol."},{"key":"38890_CR103","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1084\/jem.165.1.14","volume":"165","author":"RS Parhar","year":"1987","unstructured":"Parhar, R. S. & Lala, P. K. Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin 2. J. Exp. Med. 165, 14\u201328 (1987).","journal-title":"J. Exp. Med."},{"key":"38890_CR104","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1089\/104454903322624966","volume":"22","author":"ML Lucas","year":"2003","unstructured":"Lucas, M. L. & Heller, R. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma. DNA Cell Biol. 22, 755\u2013763 (2003).","journal-title":"DNA Cell Biol."},{"key":"38890_CR105","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1046\/j.0019-2805.2001.01342.x","volume":"105","author":"S Kakuta","year":"2002","unstructured":"Kakuta, S., Tagawa, Y., Shibata, S., Nanno, M. & Iwakura, Y. Inhibition of B16 melanoma experimental metastasis by interferon-gamma through direct inhibition of cell proliferation and activation of antitumour host mechanisms. Immunology 105, 92\u2013100 (2002).","journal-title":"Immunology"},{"key":"38890_CR106","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.ejca.2015.06.110","volume":"51","author":"A Stratigos","year":"2015","unstructured":"Stratigos, A. et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur. J. Cancer 51, 1989\u20132007 (2015).","journal-title":"Eur. J. Cancer"},{"key":"38890_CR107","doi-asserted-by":"publisher","first-page":"538","DOI":"10.7150\/jca.2.538","volume":"2","author":"JB Macdonald","year":"2011","unstructured":"Macdonald, J. B. et al. Malignant melanoma in the elderly: Different regional disease and poorer prognosis. J Cancer 2, 538\u2013543 (2011).","journal-title":"J Cancer"},{"key":"38890_CR108","first-page":"1083","volume":"7","author":"F Tas","year":"2017","unstructured":"Tas, F. & Erturk, K. Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival. Mol. Clin. Oncol. 7, 1083\u20131088 (2017).","journal-title":"Mol. Clin. Oncol."},{"key":"38890_CR109","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0167-4889(97)00004-9","volume":"1356","author":"M Durko","year":"1997","unstructured":"Durko, M., Navab, R., Shibata, H. R. & Brodt, P. Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1. Biochim. Biophys. Acta Mol. Cell Res. 1356, 271\u2013280 (1997).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"38890_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2023.02.028","author":"T Quan","year":"2023","unstructured":"Quan, T. et al. Matrix metalloproteinase-1 expression in fibroblasts accelerates dermal aging and promotes papilloma development in mouse skin. J. Investig. Dermatol. https:\/\/doi.org\/10.1016\/j.jid.2023.02.028 (2023).","journal-title":"J. Investig. Dermatol."},{"key":"38890_CR111","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s43630-021-00013-1","volume":"20","author":"N Serpone","year":"2021","unstructured":"Serpone, N. Sunscreens and their usefulness: Have we made any progress in the last two decades?. Photochem. Photobiol. 20, 189\u2013244 (2021).","journal-title":"Photochem. Photobiol."},{"key":"38890_CR112","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1046\/j.1523-1747.2003.12498.x","volume":"121","author":"R Haywood","year":"2003","unstructured":"Haywood, R., Wardman, P., Sanders, R. & Linge, C. Sunscreens inadequately protect against ultraviolet-A-induced free radicals in skin: Implications for skin aging and melanoma?. J. Invest. Dermatol. 121, 862\u2013868 (2003).","journal-title":"J. Invest. Dermatol."},{"key":"38890_CR113","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/phpp.12597","volume":"36","author":"H Luze","year":"2020","unstructured":"Luze, H., Nischwitz, S. P., Zalaudek, I., M\u00fcllegger, R. & Kamolz, L. P. DNA repair enzymes in sunscreens and their impact on photoageing: A systematic review. Photodermatol. Photoimmunol. Photomed. 36, 424\u2013432 (2020).","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"38890_CR114","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/sj.jid.5700597","volume":"127","author":"R Gupta","year":"2007","unstructured":"Gupta, R. et al. Photoprotection by 1, 25 dihydroxyvitamin D3 is associated with an increase in p53 and a decrease in nitric oxide products. J. Invest. Dermatol. 127, 707\u2013715 (2007).","journal-title":"J. Invest. Dermatol."},{"key":"38890_CR115","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jsbmb.2012.11.003","volume":"136","author":"EJ Song","year":"2013","unstructured":"Song, E. J. et al. 1\u03b1,25-Dihydroxyvitamin D3 reduces several types of UV-induced DNA damage and contributes to photoprotection. J. Steroid Biochem. Mol. Biol. 136, 131\u2013138 (2013).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"38890_CR116","unstructured":"GraphPad Prism data analyses: Version 8.4.2 for flow cytometry\/ELISA assays, Version 8.3.1 for B16F10 tumour growth analyses and Version 8.1.1 for ultraviolet radiation studies (mice\/human) and all Versions were performed on a Windows Operating System."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38890-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38890-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38890-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T10:10:41Z","timestamp":1689847841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38890-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["38890"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-38890-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]},"assertion":[{"value":"15 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors M.A. and S.P. declare competing financial interest as Executive Directors of InterK Peptide Therapeutics Limited. The remaining authors do not have any competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11702"}}